Exantas Capital (XAN) Stock Price, News & Analysis

Exantas Capital Corp. (NYSE:XAN) posted its earnings results on Wednesday, November, 4th. The company reported $0.51 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.27. Exantas Capital had a negative net margin of 347.93% and a positive trailing twelve-month return on equity of 8.10%.
Read the conference call transcript.

Exantas Capital (NYSE:XAN) pays an annual dividend of $3.30 per share and currently has a dividend yield of 21.15%. XAN has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 330.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, XAN will have a dividend payout ratio of 2,538.46% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for XAN.

Exantas Capital shares reverse split on the morning of Tuesday, February 16th 2021. The 1-3 reverse split was announced on Thursday, February 4th 2021. The number of shares owned by shareholders was adjusted after the closing bell on Monday, February 15th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split.

4 employees have rated Exantas Capital Chief Executive Officer Bill Alexander on Glassdoor.com. Bill Alexander has an approval rating of 82% among the company's employees. 85.0% of employees surveyed would recommend working at Exantas Capital to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exantas Capital investors own include EnLink Midstream (ENLC), Golar LNG Partners (GMLP), New Residential Investment (NRZ), New York Mortgage Trust (NYMT), Two Harbors Investment (TWO), Washington Prime Group (WPG), ADMA Biologics (ADMA), Hallador Energy (HNRG), Redwood Trust (RWT) and Zosano Pharma (ZSAN).